Conmed Corp (CNMD) Misses Q1 EPS by 1c; Updates Guidance
Conmed Corp (NASDAQ: CNMD) reported Q1 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $194.3 million versus the consensus estimate of $192.9 million.
Conmed Corp sees Q2 2012 EPS of $0.42-$0.47, versus the consensus of $0.45. Conmed Corp sees Q2 2012 revenue of $190-$195 million, versus the consensus of $199 million.
Conmed Corp sees FY2012 EPS of $1.75-$1.85, versus prior guidance of $1.75-$1.88 and the consensus of $1.80. Conmed Corp sees FY2012 revenue of $775-$785 million, versus prior guidance of $780-$790 million and the consensus of $782.4 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Conmed Corp sees Q2 2012 EPS of $0.42-$0.47, versus the consensus of $0.45. Conmed Corp sees Q2 2012 revenue of $190-$195 million, versus the consensus of $199 million.
Conmed Corp sees FY2012 EPS of $1.75-$1.85, versus prior guidance of $1.75-$1.88 and the consensus of $1.80. Conmed Corp sees FY2012 revenue of $775-$785 million, versus prior guidance of $780-$790 million and the consensus of $782.4 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.